Medtronicbeat Q2收入估算, 提出了2026年的指导, 并增加了其红利。 Medtronic beat Q2 earnings estimates, raised 2026 guidance, and increased its dividend.

几个机构投资者在第二季度调整了 Medtronic PLC(MDT)的股份,Bartlett & CO.和Hardman Johnston减少了股份,而Hilltop国家银行和Mattern资本管理公司增加了股份。 Several institutional investors adjusted their stakes in Medtronic PLC (MDT) during the second quarter, with Bartlett & CO. and Hardman Johnston reducing holdings, while Hilltop National Bank and Mattern Capital Management increased theirs. 该公司在8月19日报告Q2收入丰厚,在EPS上公布1.26美元,超过估计,收入为8.58亿美元,比年增长7.7%。 The company reported strong Q2 earnings on August 19, posting $1.26 EPS, surpassing estimates, and $8.58 billion in revenue, up 7.7% year-over-year. Medtronic将其2026年财政收入指导提高到每股5.60至5.66美元,并宣布季度红利为0.71美元,收益率为3.0%。 Medtronic raised its fiscal 2026 earnings guidance to $5.60–$5.66 per share and declared a quarterly dividend of $0.71, yielding 3.0%. 股票交易额为95.57美元,市场上限为1 225.9亿美元,P/E比率为26.33美元,协商一致的“通购”评级和目标价格为102.27美元。 The stock traded at $95.57, with a market cap of $122.59 billion, a P/E ratio of 26.33, and a consensus "Moderate Buy" rating and target price of $102.27.